Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Post Marketing Study of Ponstan ®500 mg Tablet Under Suspicion as Counterfeit Drug at Pharmacies


Affiliations
1 Pharmacy Study Program, Brawijaya University, Malang, Indonesia
2 Department of Clinical Pharmacy, Brawijaya University, Malang, Indonesia
3 Department of Pharmaceutics, Brawijaya University, Malang, Indonesia
     

   Subscribe/Renew Journal


Ponstan® (Mefenamic Acid 500 mg) is one of a few commonly counterfeited drugs in Indonesia. Drug counterfeiting would adversely affect consumers in terms of finances and health. Local health authority rarely conducted market inspection to address such problem. This study was conducted to determine whether Ponstan® sold at pharmacies in the vicinity of public hospital were counterfeit drugs, based on tablets physical characteristics and active substance contents with regards of the Pharmacopeia Indonesia 4th Edition requirements. This study used Ponstan® sampled from pharmacies within 1 kilometer radius of Class A or B public hospitals in Malang. The packages and tablets were physically inspected, and mefenamic acid assayed by using spectrophotometric method at 285 nm. All of the samples showed similar physical characteristics when compared to the original Ponstan®. Of total 66 tablets collected from 22 pharmacies, mefenamic acid contents were ranging from 94.58% to 111.72% of that listed on their labels, with 3.03% (2/66) contained more than 110%. It can be concluded that 96.97% (64/66) of Ponstan® tablets collected from sampled pharmacies meet the requirements of Pharmacopeia Indonesia 4th Edition, whereas the other 3.03% belong to “not conformed product” during quality control inspection.

Keywords

Ponstan®, Counterfeit, Pharmacies, Hospital, Spectrophotometry.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Winda. Perbandingan Mutu Tablet Metronidazol Generik dengan Merek Dagang Secara in Vitro. Medan: Universitas Sumatera Utara; 2009.
  • Karlina N. Optimalisasi Pengawasan Toko Obat Oleh Bidang Pemeriksaan dan Penyidikan Balai Besar Pengawas Obat dan Makanan Bandung. Jatinangor: Universitas Padjadjaran; 2008.
  • Herman. Daftar 13 Obat yang Diduga Palsu. 2014. http://www.beritasatu.com/ kesehatan/159377-daftar-13-obat-yang-diduga-palsu.html Accessed 10 October 2014.
  • Yustisia D. Pemalsuan Obat-Obatan dan Putusan Hakim Mengenai Tindak Pidana Pemalsuan Obat. Yogyakarta: Universitas Islam Indonesia; 2010.
  • Pramudiarja AY. Ponstan dan Obat Malaria Fansidar Paling Sering Dipalsukan. 2012. Accessed 11 October 2014.
  • Akib HRT. Combating Counterfeit Drugs in Indonesia: General Approaches and Strategic Action. 2007. www.powershow.com/view/396fc-m2jiy/combating_counterfeit_drugs_in_indonesia_general_approaches_and_strategic_action_powerpoint_ppt_presentation. Accessed 28 March 2015.
  • Daneswari P. Ponstan Palsu Senilai RP 4 Miliar Digerebek di Pluit. . 2013. http://warta-apoteker.com/2013/12/24/ponstan-palsu-senilai-rp4-miliar-digerebek-di-pluit/. Accessed 28 March 2015.
  • Pfizer. Counterfeit Medicines: A Clear and Present Danger. 2007.
  • Riyadi MA. Reportase Investigasi. [Television Broadcast]. Jakarta: Trans TV; 2015.
  • RI MoH. Indonesia Health Profile 2013. Ministry of Health Republic of Indonesia; 2014.
  • Singh H, Kumar R, Singh P. Development of UV Spectrophotometric Method for Estimation of Mefenamic Acid in Bulk and Pharmaceutical Dosage Forms International Journal of Pharmacy and Pharmaceutical Sciences. 2011;3(2):237-8.
  • Wiryawan A, Retnowati R, Sabarudin A. Kimia Analitik Untuk SMK. Jakarta Direktorat Pembinaan Sekolah Menengah Kejuruan; 2008.
  • Watts J, Moffat AC, Osselton MD, Widdop B. Clarke’s Analysis of Drugs and Poisons. 4 ed. London Pharmaceutical Press; 2011.
  • Waldini TK. Penetapan Kadar Asam Mefenamat dalam Sediaan Kaplet Secara Titrasi Alkalimetri. Medan: Universitas Sumatera Utara; 2013.
  • Bani-Jaber A, Hamdan I, Al-Khalidi B. Sodium Mefenamate as a Solution for the Formulation and Dissolution Problems of Mefenamic Acid. Chemical and Pharmaceutical Bulletin. 2007; 55(8):1136-40.
  • Pavia D, Lampman G, Kriz G, Vyvyan J. Introduction to Spectroscopy. 5 ed. USA: Cengage Learning; 2014.

Abstract Views: 285

PDF Views: 11




  • Post Marketing Study of Ponstan ®500 mg Tablet Under Suspicion as Counterfeit Drug at Pharmacies

Abstract Views: 285  |  PDF Views: 11

Authors

Asri Rachmadi
Pharmacy Study Program, Brawijaya University, Malang, Indonesia
Diana Lyrawati
Department of Clinical Pharmacy, Brawijaya University, Malang, Indonesia
Adeltrudis Adelsa Danimayostu
Department of Pharmaceutics, Brawijaya University, Malang, Indonesia

Abstract


Ponstan® (Mefenamic Acid 500 mg) is one of a few commonly counterfeited drugs in Indonesia. Drug counterfeiting would adversely affect consumers in terms of finances and health. Local health authority rarely conducted market inspection to address such problem. This study was conducted to determine whether Ponstan® sold at pharmacies in the vicinity of public hospital were counterfeit drugs, based on tablets physical characteristics and active substance contents with regards of the Pharmacopeia Indonesia 4th Edition requirements. This study used Ponstan® sampled from pharmacies within 1 kilometer radius of Class A or B public hospitals in Malang. The packages and tablets were physically inspected, and mefenamic acid assayed by using spectrophotometric method at 285 nm. All of the samples showed similar physical characteristics when compared to the original Ponstan®. Of total 66 tablets collected from 22 pharmacies, mefenamic acid contents were ranging from 94.58% to 111.72% of that listed on their labels, with 3.03% (2/66) contained more than 110%. It can be concluded that 96.97% (64/66) of Ponstan® tablets collected from sampled pharmacies meet the requirements of Pharmacopeia Indonesia 4th Edition, whereas the other 3.03% belong to “not conformed product” during quality control inspection.

Keywords


Ponstan®, Counterfeit, Pharmacies, Hospital, Spectrophotometry.

References